Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Chinook Contract Research Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is located in a single art unit. The company's prosecution currently involves 1 distinct examiner, showing a very specific focus for its active patent applications. This centralized structure means that the company's immediate success in the Biotechnology & Pharmaceuticals sector is tied to a single examiner's review.
LYNDSEY MARIE BECKHARDT is the busiest examiner for this portfolio, currently handling the pending office action. This single action represents the total pending office actions for the company. Because there is a single examiner and art unit, the prosecution process is centralized. Practitioners should focus on the specific examination style of LYNDSEY MARIE BECKHARDT and the procedural norms of the assigned art unit. The active prosecution requires a targeted response that addresses the specific technical concerns of the Biotechnology & Pharmaceuticals area as interpreted by the examiner. This focused environment allows for a specialized legal strategy tailored to the distinct examiner and art unit involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BECKHARDT, LYNDSEY MARIE | 1 | 27.8% | +48.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19199274 | METHODS OF ENHANCING ANTIMICROBIAL EFFICACY OF LOCAL ANESTHETICS | BECKHARDT, LYNDSEY MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19199274 | METHODS OF ENHANCING ANTIMICROBIAL EFFICACY OF LOCAL ANESTHETICS | BECKHARDT, LYNDSEY MARIE | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19199274 | METHODS OF ENHANCING ANTIMICROBIAL EFFICACY OF LOCAL ANESTHETICS | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Final Rejection | — | Pending | May 05, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChinook Contract Research Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lyndsey Marie Beckhardt has the most, with 1 of Chinook Contract Research Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
